Jasbir Dhaliwal
Cincinnati Children's Hospital Medical Center
Appearances
- DateMay 8, 2023SOCIETY: AGA
Moderators
Cincinnati Children's Hospital Medical CenterIcahn School of Medicine at Mount Sinai Department of Pediatrics - DateMay 8, 2023BACKGROUND: Tumor necrosis factor inhibitors (TNFi) are a mainstay of pediatric Crohn’s disease (PCD) therapy; yet not all patients respond, and others lose response over time. Combination therapy with methotrexate may improve response; however, this has not been rigorously evaluated…
Presenter
Speakers
Cincinnati Children’s Hospital Medical CenterCincinnati Children's Hospital Medical Center - DateMay 18, 2024To date, genome-wide association studies (GWAS) have identified 418 independent genetic risk loci contributing to inflammatory bowel disease (IBD) and its two subtypes: ulcerative colitis (UC) and Crohn’s disease (CD) (PMID:37156999)…
Presenter
Speakers
Cincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical CenterCincinnati Children’s Hospital Medical Center